| Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... Circulation 129 (3), 399-410, 2014 | 29343* | 2014 |
| Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... Circulation 131 (4), 434-441, 2015 | 14783 | 2015 |
| The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries AP Ambrosy, GC Fonarow, J Butler, O Chioncel, SJ Greene, ... Journal of the American College of Cardiology 63 (12), 1123-1133, 2014 | 1260 | 2014 |
| Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study CSP Lam, VL Roger, RJ Rodeheffer, BA Borlaug, FT Enders, MM Redfield Journal of the American College of Cardiology 53 (13), 1119-1126, 2009 | 867 | 2009 |
| Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction BA Borlaug, RA Nishimura, P Sorajja, CSP Lam, MM Redfield Circulation: Heart Failure 3 (5), 588-595, 2010 | 715 | 2010 |
| Epidemiology and clinical course of heart failure with preserved ejection fraction CSP Lam, E Donal, E Kraigher‐Krainer, RS Vasan European journal of heart failure 13 (1), 18-28, 2011 | 652 | 2011 |
| CLINICAL PERSPECTIVE CSP Lam, VL Roger, RJ Rodeheffer, F Bursi, BA Borlaug, SR Ommen, ... Circulation 115 (15), 1982-1990, 2007 | 627* | 2007 |
| CLINICAL PERSPECTIVE BA Borlaug, V Melenovsky, SD Russell, K Kessler, K Pacak, LC Becker, ... Circulation 114 (20), 2138-2147, 2006 | 605 | 2006 |
| Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction BA Borlaug, TP Olson, CSP Lam, KS Flood, A Lerman, BD Johnson, ... Journal of the American College of Cardiology 56 (11), 845-854, 2010 | 561 | 2010 |
| Age-associated increases in pulmonary artery systolic pressure in the general population CSP Lam, BA Borlaug, GC Kane, FT Enders, RJ Rodeheffer, MM Redfield Circulation 119 (20), 2663, 2009 | 389 | 2009 |
| Contractility and ventricular systolic stiffening in hypertensive heart disease: insights into the pathogenesis of heart failure with preserved ejection fraction BA Borlaug, CSP Lam, VL Roger, RJ Rodeheffer, MM Redfield Journal of the American College of Cardiology 54 (5), 410-418, 2009 | 363 | 2009 |
| Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction RJ Mentz, JP Kelly, TG von Lueder, AA Voors, CSP Lam, MR Cowie, ... Journal of the American College of Cardiology 64 (21), 2281-2293, 2014 | 357 | 2014 |
| Developing therapies for heart failure with preserved ejection fraction: current state and future directions J Butler, GC Fonarow, MR Zile, CS Lam, L Roessig, EB Schelbert, ... JACC: Heart Failure 2 (2), 97-112, 2014 | 300 | 2014 |
| Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ... New England Journal of Medicine 381 (17), 1609-1620, 2019 | 293 | 2019 |
| New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes M Senni, WJ Paulus, A Gavazzi, AG Fraser, J Díez, SD Solomon, ... European heart journal 35 (40), 2797-2815, 2014 | 285 | 2014 |
| Pulmonary pressures and death in heart failure: a community study F Bursi, SM McNallan, MM Redfield, VT Nkomo, CSP Lam, SA Weston, ... Journal of the American College of Cardiology 59 (3), 222-231, 2012 | 260 | 2012 |
| Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community CSP Lam, A Lyass, E Kraigher-Krainer, JM Massaro, DS Lee, JE Ho, ... Circulation 124 (1), 24-30, 2011 | 239 | 2011 |
| Left ventricular function and exercise capacity J Grewal, RB McCully, GC Kane, C Lam, PA Pellikka Jama 301 (3), 286-294, 2009 | 225 | 2009 |
| Heart failure with preserved ejection fraction: a clinical dilemma M Komajda, CSP Lam European heart journal 35 (16), 1022-1032, 2014 | 210 | 2014 |
| Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL 2 study M Kosiborod, CSP Lam, S Kohsaka, DJ Kim, A Karasik, J Shaw, N Tangri, ... Journal of the American College of Cardiology 71 (23), 2628-2639, 2018 | 209 | 2018 |
